Avomed Limited 10028026 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is that of the provision of consultancy services. Digita Accounts Production Advanced 6.30.9574.0 true 10028026 2024-07-01 2025-06-30 10028026 2025-06-30 10028026 bus:OrdinaryShareClass1 2025-06-30 10028026 bus:OrdinaryShareClass2 2025-06-30 10028026 core:CurrentFinancialInstruments 2025-06-30 10028026 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 10028026 core:Non-currentFinancialInstruments 2025-06-30 10028026 core:Non-currentFinancialInstruments core:AfterOneYear 2025-06-30 10028026 core:OfficeEquipment 2025-06-30 10028026 bus:SmallEntities 2024-07-01 2025-06-30 10028026 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 10028026 bus:FilletedAccounts 2024-07-01 2025-06-30 10028026 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 10028026 bus:RegisteredOffice 2024-07-01 2025-06-30 10028026 bus:Director1 2024-07-01 2025-06-30 10028026 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 10028026 bus:OrdinaryShareClass2 2024-07-01 2025-06-30 10028026 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 10028026 bus:Agent1 2024-07-01 2025-06-30 10028026 core:OfficeEquipment 2024-07-01 2025-06-30 10028026 countries:AllCountries 2024-07-01 2025-06-30 10028026 2024-06-30 10028026 core:OfficeEquipment 2024-06-30 10028026 2023-07-01 2024-06-30 10028026 2024-06-30 10028026 bus:OrdinaryShareClass1 2024-06-30 10028026 bus:OrdinaryShareClass2 2024-06-30 10028026 core:CurrentFinancialInstruments 2024-06-30 10028026 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 10028026 core:Non-currentFinancialInstruments 2024-06-30 10028026 core:Non-currentFinancialInstruments core:AfterOneYear 2024-06-30 10028026 core:OfficeEquipment 2024-06-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10028026

Avomed Limited
Unaudited Filleted Financial Statements
for the Year Ended 30 June 2025

Avomed Limited

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 8

Avomed Limited

Company Information

Director | Mr S Coles

Registered office | Unit 12 Old Mills Industrial Estate Paulton Bristol BS39 7SU

Accountants | Fuller & Roper Limited Unit 12 Old Mills Industrial Estate Paulton Bristol BS39 7SU

Avomed Limited

(Registration number: 10028026)
Balance Sheet as at 30 June 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 5 | - | 321
Current assets |  |  |
Debtors | 6 | 34,446 | 79,602
Cash at bank and in hand |  | 62,351 | 31,584
|  | 96,797 | 111,186
Creditors: Amounts falling due within one year | 7 | (74,432) | (81,344)
Net current assets |  | 22,365 | 29,842
Total assets less current liabilities |  | 22,365 | 30,163
Creditors: Amounts falling due after more than one year | 7 | (833) | (10,833)
Net assets |  | 21,532 | 19,330
Capital and reserves |  |  |
Called up share capital | 8 | 200 | 200
Retained earnings |  | 21,332 | 19,130
Shareholders' funds |  | 21,532 | 19,330

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Avomed Limited

(Registration number: 10028026)
Balance Sheet as at 30 June 2025

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 11 March 2026

......................................... Mr S Coles Director

Avomed Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

1 | General information

Avomed Limited is a private company, limited by shares, domiciled in England and Wales. The company’s registration number is 10028026. The registered office is Unit 12 Old Mills Industrial Estate, Paulton, Bristol, BS39 7SU.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Avomed Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Furniture, fittings and equipment | 33% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Avomed Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 2).

4 | Profit before tax

Arrived at after charging/(crediting)

| 2025 £ | 2024 £
Depreciation expense | 321 | 392

Avomed Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

5 | Tangible assets

| Office equipment £ | Total £
Cost or valuation
At 1 July 2024 | 11,049 | 11,049
At 30 June 2025 | 11,049 | 11,049
Depreciation
At 1 July 2024 | 10,728 | 10,728
Charge for the year | 321 | 321
At 30 June 2025 | 11,049 | 11,049
Carrying amount
At 30 June 2025 | - | -
At 30 June 2024 | 321 | 321

6 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 22,938 | 63,310
Other debtors | 11,508 | 16,292
| 34,446 | 79,602

7 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 9 | 10,000 | 10,000
Trade creditors |  | 19,967 | 16,979
Taxation and social security |  | 41,056 | 51,636
Accruals and deferred income |  | 3,119 | 2,640
Other creditors |  | 290 | 89
|  | 74,432 | 81,344

Avomed Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 9 | 833 | 10,833

8 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
A shares of £1 each | 100 | 100 | 100 | 100
B shares of £1 each | 100 | 100 | 100 | 100
| 200 | 200 | 200 | 200

9 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 833 | 10,833

Current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 10,000 | 10,000

10 | Related party transactions

Included within other creditors is a loan of £185 (2024 - £88) from Mr S Coles, a director of the company. This amount is unsecured, interest free and repayable on demand.
Included within other debtors is a loan of £nil (2024 - £15,793) to Avomed International Limited, a company under common control. This amount is unsecured, interest free and repayable on demand.
Included within other debtors is a loan of £11,505 (2024 - £498) to Farrington Holdings Limited, a company under common control. This amount is unsecured, interest free and repayable on demand.